Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

270 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Completed

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +57 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

NCT05678218

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +15 more
Locations
  • University Hospital of Ghent Ghent, Belgium
  • Maastricht UMC+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Completed

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

NCT02375880

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +15 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

NCT03377179

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Emory University Atlanta, Georgia, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT05788484

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
Locations
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions